Medical Management of Diabetes and Heart Disease - part 1 pps

... York, NY 10 016 tel: 21 2-6 9 6-9 000; fax: 21 2-6 8 5-4 540 Eastern Hemisphere Distribution Marcel Dekker AG Hutgasse 4, Postfach 812 , CH-40 01 Basel, Switzerland tel: 4 1- 6 1- 2 6 1- 8 482; fax: 4 1- 6 1- 2 6 1- 8 896 World ... Hodis, and Wendy J. Mack 12 . Management of Patients with Diabetes and Coronary Artery Disease 18 5 William E. Boden 13 . Pathoph...

Ngày tải lên: 14/08/2014, 07:20

... ischemic heart disease. JAMA 19 98; 279 :19 55 19 61. 52. Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the Framing- ham Study. Am Heart J 19 85; 11 0 :11 00 11 07. 53. Kannel ... Circula- tion 19 99; 10 0 :12 3 12 8. 50. Despre ´ s J-P. The insulin resistance-dyslipidemia syndrome: The most prevalent cause of coronary artery disease? Can Med Assoc...

Ngày tải lên: 14/08/2014, 07:20

... high-risk patients with diabetes. The MICRO-HOPE study. Diabetes Care 19 96; 19 :12 25 12 28. 30. Godsland JK, Stevenson JC. Insulin resistance: syndrome or tendency? Lancet 19 95; 346 :10 0 10 3. 31. ... 2 diabetes: a 15 -year follow-up from the time of diagnosis. Diabetes Care 19 98; 21: 18 61 18 69. 64. Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali JR, Valensi P. Coronary...

Ngày tải lên: 14/08/2014, 07:20

... with type 2 diabetes. Proc Assoc Am Physicians 19 99; 11 1: 313 – 318 . 58 Cefalu of coronary heart disease: results from two population studies in Finland. Diabetes Care 19 79; 2 :13 1 14 1. 21. White MF, ... Care 19 98; 21: 113 8– 11 45. 7. Harris MI. Diabetes in America: Epidemiology and scope of the problem. Diabetes Care 19 98; 21: C 11 C14. 8. Kannel WB, Hjortland...

Ngày tải lên: 14/08/2014, 07:20

... 10 6 30–80 55–80 5 15 10 –20 IDL 1. 006 1. 019 5 10 ϫ 10 6 25–35 20–50 20–40 15 –25 LDL 1. 019 1. 063 2.3 ϫ 10 6 18 –25 5 15 40–50 20–25 HDL 1. 063 1. 21 1.7–3.6 ϫ 10 6 5 12 5 10 15 –25 20–30 Density: g/dL; MW: ... Intern Med 19 97; 15 7:2 413 –2446. 86. 19 99 World Health Organization-International Society of Hypertension guidelines for the management of hypertension...

Ngày tải lên: 14/08/2014, 07:20

... (IRS -1 and IRS-2), and activation of the phosphoinositol 3′ kinase (PI-3′-K) pathway. On the other hand, cell growth and differentiation are regu- lated primarily by the SHC, GRB-2, and the MAP-kinase ... system. N Engl J Med 19 96; 334:374–3 81. 9. Chen YD-I, Reaven GM. Insulin resistance and atherosclerosis. Diabetes Rev 19 97; 5:3 31 342. Syndrome X 11 9 Each of the b...

Ngày tải lên: 14/08/2014, 07:20

... Endocrinol Metab 20 01; 86 :11 75 11 80. Diagnosis of Heart Disease in Diabetic and Prediabetic Subjects 16 5 lar risk factors like hypertension, dyslipidemia, family history of CAD, and smok- ing, as well ... patterns of insulin secretion in non-insulin dependent diabetes. N Engl J Med 19 88; 318 :12 31 12 39. 27. Polonsky KS, Sturis J, Bell BI. Non-insulin-dependent diabet...

Ngày tải lên: 14/08/2014, 07:20

... PTCA- and CABG-treated patients even in subgroups of diabetes and three-vessel disease ( 31) . In addition to the randomized trials com- paring PCI and CABG, three large, single-center registries and ... three-vessel disease, and this is consistent with the 19 81 19 94 Emory experience where only 15 % of insulin- dependent diabetics with three-vessel disease requiring r...

Ngày tải lên: 14/08/2014, 07:20

... diabetes, 11 0 11 3 Fibrinolytic agents, CAD, 19 1 19 3 MI, 19 1 19 3 type 2 diabetes, 11 3 11 4 Fibrinolytic system, schematic, 54 Fibrinolytic Therapy Trialists’ Collabora- tive Group, 19 1 19 2 Fibrinopeptide ... 12 6 metformin, 11 2 obesity, 14 9 15 0 OSA, 15 5 15 6 PAI -1 , 15 3 15 4 prevalence, 14 9 thrombosis, 15 3 15 4 treatment, 15 6 15 8 troglitazone, 11 2 Postexerci...

Ngày tải lên: 14/08/2014, 07:20